Pharmaceutical companies have already raised the price of over 800 brand-name prescription drugs this year. Nearly all the ...

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

A lawsuit filed by the Cabell County Commission and the City of Huntington against some of the country’s biggest drug ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

The program, called 340b, allows eligible safety net providers to purchase drugs at deeply discounted prices, then reinvest ...